DUNHAM TRUST Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.9K Hold
800
– – 0.02% 154
2026
Q2
$46.1K Buy
+800
New +$45.9K 0.02% 156
2025
Q4
$43.2K Buy
+800
New +$38.5K 0.03% 156

Other funds holding BMY

DUNHAM TRUST Co's BMY Position: Q3 2026 in Review

DUNHAM TRUST Co held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 800 shares worth $49.9K. The position accounts for 0.02% of the portfolio, ranked #154.

DUNHAM TRUST Co first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • DUNHAM TRUST Co held 800 shares of Bristol-Myers Squibb worth $49.9K as of Q3 2026.
  • DUNHAM TRUST Co left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.02% of DUNHAM TRUST Co's portfolio in Q3 2026, its #154 holding.
  • DUNHAM TRUST Co first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.